Appropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancer

Journal of Clinical Oncology

Volumn 33, Issue 3, 2015, Pages 232-234

  Lyman, Gary H ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURVIVAL; EARLY CANCER; EDITORIAL; HUMAN; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; TUMOR BIOPSY; ADJUVANT THERAPY; BREAST NEOPLASMS; FEMALE; LYMPH NODE; PATHOLOGY; PROCEDURES;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; NEOADJUVANT THERAPY; SENTINEL LYMPH NODE BIOPSY;

EID: 84921756315     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.9838     Document Type: Editorial

References (20)

1. Sledge GW, Mamounas EP, Hortobagyi GN, et al: Past, present, and future challenges in breast cancer treatment. J Clin Oncol 32:1979-1986, 2014
2. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822, 1996
3. Buchholz TA, Somerfield MR, Griggs JJ, et al: Margins for breastconserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology consensus guideline. J Clin Oncol 32:1502-1506, 2014
4. Lyman GH, Giuliano AE, Somerfield MR, et al: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in earlystage breast cancer. J Clin Oncol 23:7703-7720, 2005
5. Cox CE, Bass SS, McCann CR, et al: Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med 51:525-542, 2000
6. Shivers SC, Wang X, Li W, et al: Molecular staging of malignant melanoma: Correlation with clinical outcome. JAMA 280:1410-1415, 1998
7. Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: A metaanalysis. Cancer 106:4-16, 2006
8. Lyman GH, Temin S, Edge SB, et al: Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 32:1365-1383, 2014
9. Giuliano AE, Hunt KK, Ballman KV, et al: Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 305:569-575, 2011
10. Amiri-Kordestani L, Wedam S, Zhang L, et al: First FDA approval of neoadjuvant therapy for breast cancer: Pertuzumab for the treatment of patients with HER2-positive breast cancer. Clin Cancer Res 20:5359-5364, 2014
11. Cortazar P, Zhang L, Untch M, et al: Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis. Lancet 384:164-172, 2014
12. Prowell TM, Pazdur R: Pathological complete response and accelerated drug approval in early breast cancer. N Engl J Med 366:2438-2441, 2012
13. Mamounas EP, Brown A, Anderson S, et al: Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: Results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23:2694-2702, 2005
14. Boughey JC, Suman VJ, Mittendorf EA, et al: Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (Alliance) clinical trial. JAMA 310:1455-1461, 2013
15. Kuehn T, Bauerfeind I, Fehm T, et al: Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 14:609-618, 2013
16. Fu JF, Chen HL, Yang J, et al: Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: A meta-analysis. PLoS One 9:e105316, 2014
17. Boileau J-F, Poirier B, Basik M, et al: Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: The SN FNAC study. J Clin Oncol 33:258-264, 2015
18. Marks LB, Prosnitz LR: Reducing local therapy in patients responding to preoperative systemic therapy: Are we outsmarting ourselves? J Clin Oncol 32:491-493, 2014
19. White J, Mamounas E: Locoregional radiotherapy in patients with breast cancer responding to neoadjuvant chemotherapy: A paradigm for treatment individualization. J Clin Oncol 32:494-495, 2014
20. Jagsi R, Chadha M, Moni J, et al: Radiation field design in the ACOSOG Z0011 (Alliance) trial. J Clin Oncol 32:3600-3606, 2014